Financhill
Sell
42

JDOC Quote, Financials, Valuation and Earnings

Last price:
$49.01
Seasonality move :
4.97%
Day range:
$48.98 - $48.98
52-week range:
$47.67 - $63.49
Dividend yield:
5.75%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
122
Avg. volume:
225
1-year change:
-15.66%
Market cap:
--
Revenue:
--
EPS (TTM):
--

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
JDOC
JPMorgan Healthcare Leaders ETF
-- -- -- -- --
AGNG
Global X Aging Population ETF
-- -- -- -- --
BME
Blackrock Health Sciences Trust
-- -- -- -- --
BMED
iShares Health Innovation Active ETF
-- -- -- -- --
HART
NYLI Healthy Hearts ETF
-- -- -- -- --
HRTS
Tema GLP-1, Obesity & Cardiometabolic ETF
-- -- -- -- --
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
JDOC
JPMorgan Healthcare Leaders ETF
$48.98 -- -- -- $0.33 5.75% --
AGNG
Global X Aging Population ETF
$31.14 -- -- -- $0.15 0.8% --
BME
Blackrock Health Sciences Trust
$35.75 -- -- -- $0.26 5.16% --
BMED
iShares Health Innovation Active ETF
$23.80 -- -- -- $0.01 0% --
HART
NYLI Healthy Hearts ETF
$29.82 -- -- -- $0.15 1.37% --
HRTS
Tema GLP-1, Obesity & Cardiometabolic ETF
$27.46 -- -- -- $0.47 0.52% --
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
JDOC
JPMorgan Healthcare Leaders ETF
-- 0.940 -- --
AGNG
Global X Aging Population ETF
-- 0.837 -- --
BME
Blackrock Health Sciences Trust
-- 0.994 -- --
BMED
iShares Health Innovation Active ETF
-- 1.111 -- --
HART
NYLI Healthy Hearts ETF
-- 1.019 -- --
HRTS
Tema GLP-1, Obesity & Cardiometabolic ETF
-- 1.048 -- --
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
JDOC
JPMorgan Healthcare Leaders ETF
-- -- -- -- -- --
AGNG
Global X Aging Population ETF
-- -- -- -- -- --
BME
Blackrock Health Sciences Trust
-- -- -- -- -- --
BMED
iShares Health Innovation Active ETF
-- -- -- -- -- --
HART
NYLI Healthy Hearts ETF
-- -- -- -- -- --
HRTS
Tema GLP-1, Obesity & Cardiometabolic ETF
-- -- -- -- -- --

JPMorgan Healthcare Leaders ETF vs. Competitors

  • Which has Higher Returns JDOC or AGNG?

    Global X Aging Population ETF has a net margin of -- compared to JPMorgan Healthcare Leaders ETF's net margin of --. JPMorgan Healthcare Leaders ETF's return on equity of -- beat Global X Aging Population ETF's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    JDOC
    JPMorgan Healthcare Leaders ETF
    -- -- --
    AGNG
    Global X Aging Population ETF
    -- -- --
  • What do Analysts Say About JDOC or AGNG?

    JPMorgan Healthcare Leaders ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Global X Aging Population ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that JPMorgan Healthcare Leaders ETF has higher upside potential than Global X Aging Population ETF, analysts believe JPMorgan Healthcare Leaders ETF is more attractive than Global X Aging Population ETF.

    Company Buy Ratings Hold Ratings Sell Ratings
    JDOC
    JPMorgan Healthcare Leaders ETF
    0 0 0
    AGNG
    Global X Aging Population ETF
    0 0 0
  • Is JDOC or AGNG More Risky?

    JPMorgan Healthcare Leaders ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Global X Aging Population ETF has a beta of 0.765, suggesting its less volatile than the S&P 500 by 23.536%.

  • Which is a Better Dividend Stock JDOC or AGNG?

    JPMorgan Healthcare Leaders ETF has a quarterly dividend of $0.33 per share corresponding to a yield of 5.75%. Global X Aging Population ETF offers a yield of 0.8% to investors and pays a quarterly dividend of $0.15 per share. JPMorgan Healthcare Leaders ETF pays -- of its earnings as a dividend. Global X Aging Population ETF pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios JDOC or AGNG?

    JPMorgan Healthcare Leaders ETF quarterly revenues are --, which are smaller than Global X Aging Population ETF quarterly revenues of --. JPMorgan Healthcare Leaders ETF's net income of -- is lower than Global X Aging Population ETF's net income of --. Notably, JPMorgan Healthcare Leaders ETF's price-to-earnings ratio is -- while Global X Aging Population ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for JPMorgan Healthcare Leaders ETF is -- versus -- for Global X Aging Population ETF. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    JDOC
    JPMorgan Healthcare Leaders ETF
    -- -- -- --
    AGNG
    Global X Aging Population ETF
    -- -- -- --
  • Which has Higher Returns JDOC or BME?

    Blackrock Health Sciences Trust has a net margin of -- compared to JPMorgan Healthcare Leaders ETF's net margin of --. JPMorgan Healthcare Leaders ETF's return on equity of -- beat Blackrock Health Sciences Trust's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    JDOC
    JPMorgan Healthcare Leaders ETF
    -- -- --
    BME
    Blackrock Health Sciences Trust
    -- -- --
  • What do Analysts Say About JDOC or BME?

    JPMorgan Healthcare Leaders ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Blackrock Health Sciences Trust has an analysts' consensus of -- which suggests that it could fall by --. Given that JPMorgan Healthcare Leaders ETF has higher upside potential than Blackrock Health Sciences Trust, analysts believe JPMorgan Healthcare Leaders ETF is more attractive than Blackrock Health Sciences Trust.

    Company Buy Ratings Hold Ratings Sell Ratings
    JDOC
    JPMorgan Healthcare Leaders ETF
    0 0 0
    BME
    Blackrock Health Sciences Trust
    0 0 0
  • Is JDOC or BME More Risky?

    JPMorgan Healthcare Leaders ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Blackrock Health Sciences Trust has a beta of 0.710, suggesting its less volatile than the S&P 500 by 28.992%.

  • Which is a Better Dividend Stock JDOC or BME?

    JPMorgan Healthcare Leaders ETF has a quarterly dividend of $0.33 per share corresponding to a yield of 5.75%. Blackrock Health Sciences Trust offers a yield of 5.16% to investors and pays a quarterly dividend of $0.26 per share. JPMorgan Healthcare Leaders ETF pays -- of its earnings as a dividend. Blackrock Health Sciences Trust pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios JDOC or BME?

    JPMorgan Healthcare Leaders ETF quarterly revenues are --, which are smaller than Blackrock Health Sciences Trust quarterly revenues of --. JPMorgan Healthcare Leaders ETF's net income of -- is lower than Blackrock Health Sciences Trust's net income of --. Notably, JPMorgan Healthcare Leaders ETF's price-to-earnings ratio is -- while Blackrock Health Sciences Trust's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for JPMorgan Healthcare Leaders ETF is -- versus -- for Blackrock Health Sciences Trust. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    JDOC
    JPMorgan Healthcare Leaders ETF
    -- -- -- --
    BME
    Blackrock Health Sciences Trust
    -- -- -- --
  • Which has Higher Returns JDOC or BMED?

    iShares Health Innovation Active ETF has a net margin of -- compared to JPMorgan Healthcare Leaders ETF's net margin of --. JPMorgan Healthcare Leaders ETF's return on equity of -- beat iShares Health Innovation Active ETF's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    JDOC
    JPMorgan Healthcare Leaders ETF
    -- -- --
    BMED
    iShares Health Innovation Active ETF
    -- -- --
  • What do Analysts Say About JDOC or BMED?

    JPMorgan Healthcare Leaders ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand iShares Health Innovation Active ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that JPMorgan Healthcare Leaders ETF has higher upside potential than iShares Health Innovation Active ETF, analysts believe JPMorgan Healthcare Leaders ETF is more attractive than iShares Health Innovation Active ETF.

    Company Buy Ratings Hold Ratings Sell Ratings
    JDOC
    JPMorgan Healthcare Leaders ETF
    0 0 0
    BMED
    iShares Health Innovation Active ETF
    0 0 0
  • Is JDOC or BMED More Risky?

    JPMorgan Healthcare Leaders ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison iShares Health Innovation Active ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock JDOC or BMED?

    JPMorgan Healthcare Leaders ETF has a quarterly dividend of $0.33 per share corresponding to a yield of 5.75%. iShares Health Innovation Active ETF offers a yield of 0% to investors and pays a quarterly dividend of $0.01 per share. JPMorgan Healthcare Leaders ETF pays -- of its earnings as a dividend. iShares Health Innovation Active ETF pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios JDOC or BMED?

    JPMorgan Healthcare Leaders ETF quarterly revenues are --, which are smaller than iShares Health Innovation Active ETF quarterly revenues of --. JPMorgan Healthcare Leaders ETF's net income of -- is lower than iShares Health Innovation Active ETF's net income of --. Notably, JPMorgan Healthcare Leaders ETF's price-to-earnings ratio is -- while iShares Health Innovation Active ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for JPMorgan Healthcare Leaders ETF is -- versus -- for iShares Health Innovation Active ETF. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    JDOC
    JPMorgan Healthcare Leaders ETF
    -- -- -- --
    BMED
    iShares Health Innovation Active ETF
    -- -- -- --
  • Which has Higher Returns JDOC or HART?

    NYLI Healthy Hearts ETF has a net margin of -- compared to JPMorgan Healthcare Leaders ETF's net margin of --. JPMorgan Healthcare Leaders ETF's return on equity of -- beat NYLI Healthy Hearts ETF's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    JDOC
    JPMorgan Healthcare Leaders ETF
    -- -- --
    HART
    NYLI Healthy Hearts ETF
    -- -- --
  • What do Analysts Say About JDOC or HART?

    JPMorgan Healthcare Leaders ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand NYLI Healthy Hearts ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that JPMorgan Healthcare Leaders ETF has higher upside potential than NYLI Healthy Hearts ETF, analysts believe JPMorgan Healthcare Leaders ETF is more attractive than NYLI Healthy Hearts ETF.

    Company Buy Ratings Hold Ratings Sell Ratings
    JDOC
    JPMorgan Healthcare Leaders ETF
    0 0 0
    HART
    NYLI Healthy Hearts ETF
    0 0 0
  • Is JDOC or HART More Risky?

    JPMorgan Healthcare Leaders ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison NYLI Healthy Hearts ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock JDOC or HART?

    JPMorgan Healthcare Leaders ETF has a quarterly dividend of $0.33 per share corresponding to a yield of 5.75%. NYLI Healthy Hearts ETF offers a yield of 1.37% to investors and pays a quarterly dividend of $0.15 per share. JPMorgan Healthcare Leaders ETF pays -- of its earnings as a dividend. NYLI Healthy Hearts ETF pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios JDOC or HART?

    JPMorgan Healthcare Leaders ETF quarterly revenues are --, which are smaller than NYLI Healthy Hearts ETF quarterly revenues of --. JPMorgan Healthcare Leaders ETF's net income of -- is lower than NYLI Healthy Hearts ETF's net income of --. Notably, JPMorgan Healthcare Leaders ETF's price-to-earnings ratio is -- while NYLI Healthy Hearts ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for JPMorgan Healthcare Leaders ETF is -- versus -- for NYLI Healthy Hearts ETF. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    JDOC
    JPMorgan Healthcare Leaders ETF
    -- -- -- --
    HART
    NYLI Healthy Hearts ETF
    -- -- -- --
  • Which has Higher Returns JDOC or HRTS?

    Tema GLP-1, Obesity & Cardiometabolic ETF has a net margin of -- compared to JPMorgan Healthcare Leaders ETF's net margin of --. JPMorgan Healthcare Leaders ETF's return on equity of -- beat Tema GLP-1, Obesity & Cardiometabolic ETF's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    JDOC
    JPMorgan Healthcare Leaders ETF
    -- -- --
    HRTS
    Tema GLP-1, Obesity & Cardiometabolic ETF
    -- -- --
  • What do Analysts Say About JDOC or HRTS?

    JPMorgan Healthcare Leaders ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Tema GLP-1, Obesity & Cardiometabolic ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that JPMorgan Healthcare Leaders ETF has higher upside potential than Tema GLP-1, Obesity & Cardiometabolic ETF, analysts believe JPMorgan Healthcare Leaders ETF is more attractive than Tema GLP-1, Obesity & Cardiometabolic ETF.

    Company Buy Ratings Hold Ratings Sell Ratings
    JDOC
    JPMorgan Healthcare Leaders ETF
    0 0 0
    HRTS
    Tema GLP-1, Obesity & Cardiometabolic ETF
    0 0 0
  • Is JDOC or HRTS More Risky?

    JPMorgan Healthcare Leaders ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Tema GLP-1, Obesity & Cardiometabolic ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock JDOC or HRTS?

    JPMorgan Healthcare Leaders ETF has a quarterly dividend of $0.33 per share corresponding to a yield of 5.75%. Tema GLP-1, Obesity & Cardiometabolic ETF offers a yield of 0.52% to investors and pays a quarterly dividend of $0.47 per share. JPMorgan Healthcare Leaders ETF pays -- of its earnings as a dividend. Tema GLP-1, Obesity & Cardiometabolic ETF pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios JDOC or HRTS?

    JPMorgan Healthcare Leaders ETF quarterly revenues are --, which are smaller than Tema GLP-1, Obesity & Cardiometabolic ETF quarterly revenues of --. JPMorgan Healthcare Leaders ETF's net income of -- is lower than Tema GLP-1, Obesity & Cardiometabolic ETF's net income of --. Notably, JPMorgan Healthcare Leaders ETF's price-to-earnings ratio is -- while Tema GLP-1, Obesity & Cardiometabolic ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for JPMorgan Healthcare Leaders ETF is -- versus -- for Tema GLP-1, Obesity & Cardiometabolic ETF. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    JDOC
    JPMorgan Healthcare Leaders ETF
    -- -- -- --
    HRTS
    Tema GLP-1, Obesity & Cardiometabolic ETF
    -- -- -- --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

NVIDIA vs Broadcom Stock: Which Is Best?
NVIDIA vs Broadcom Stock: Which Is Best?

NVIDIA (NASDAQ:NVDA) and Broadcom (NASDAQ:AVGO) are two of the hottest…

Why Did Forge Global Stock Go Down?
Why Did Forge Global Stock Go Down?

Shares of Forge Global (NYSE:FRGE), a platform that allows accredited…

Is GlobalFoundries On The Verge Of A Breakout?
Is GlobalFoundries On The Verge Of A Breakout?

GLOBALFOUNDRIES Inc. (NASDAQ:GFS) is as a semiconductor foundry whose chips…

Stock Ideas

Buy
67
Is MSFT Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 38x

Buy
68
Is NVDA Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 45x

Sell
39
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Buy
58
WIX alert for May 22

Wix.com [WIX] is up 1.88% over the past day.

Buy
81
DY alert for May 22

Dycom Industries [DY] is down 0% over the past day.

Sell
50
FICO alert for May 22

Fair Isaac [FICO] is down 0.46% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock